Pharmacological Properties of Natural Products

Natural products represent a vast reservoir of chemically diverse molecules that have shaped the development of modern therapeutics. These compounds, which encompass alkaloids, terpenoids, polyphenols and peptides, exhibit a wide array of pharmacological activities including antimicrobial, anticancer, anti-inflammatory and antioxidant effects. Advances in analytical chemistry and synthetic biology have enabled the systematic characterisation of complex extracts and the optimisation of bioactive scaffolds. Integrative approaches combining genomics, metabolomics and computational modelling now permit the rapid identification of novel natural-product leads and the improvement of their pharmacokinetic profiles. Despite challenges in standardisation, scalability and precise mechanism elucidation, recent innovations have revitalised interest in plant, microbial and marine sources. The global significance of this field is reflected in diverse applications, from new antibiotic classes to immunomodulatory agents and formulations that enhance delivery to target tissues.

Research from Nature Portfolio

Recent studies have leveraged high-throughput genome mining to unveil previously uncharacterised microbial biosynthetic clusters, leading to the discovery of novel polyketide and nonribosomal peptide antibiotics active against drug-resistant pathogens. In parallel, an artificial-intelligence framework has been applied to plant metabolite libraries, predicting polyphenol structures with potent in vivo anti-inflammatory activity and confirming efficacy in rodent models of colitis. Furthermore, a mechanistic investigation has elucidated how selected fungal secondary metabolites can modulate T-cell signalling by binding to immune-checkpoint proteins, thereby opening avenues for natural-product-derived immunotherapies.

Pharmacological Properties of Natural Products publication trend

The graph below shows the total number of articles in pharmacological properties of natural products across all publications each year (not limited to Nature Index journals).

Technical terms

Secondary metabolites: Bioactive small molecules produced by organisms that are not directly involved in primary metabolism but confer ecological or defensive advantages.

Bioavailability: The proportion of an administered substance that reaches the systemic circulation and is available for therapeutic action.

High-throughput screening: Automated evaluation of large chemical libraries or extracts to identify compounds with desired biological activities.

Pharmacokinetics: The study of how a compound is absorbed, distributed, metabolised and excreted by the body.

Metabolomics: Comprehensive analysis of metabolites within a biological system, enabling the profiling of bioactive compounds and their pathways.

References

1. Development of an adhesive tablet for the delivery of Diospyros villosa root for the treatment of oral cavity diseases. Journal of Drug Delivery Science and Technology (2023).
2. Traditional Uses, Pharmacological Activities, and Phytochemical Analysis of Diospyros mespiliformis Hochst. ex. A. DC (Ebenaceae): A Review. Molecules (2023).
3. Anticancer therapeutic potential of genus Diospyros: From phytochemistry to clinical applications—A review. Food Science & Nutrition (2024).
4. Utilization of Secondary Metabolites in Algae Kappaphycus alvarezii as a Breast Cancer Drug with a Computational Method. Pharmacognosy Journal (2022).